Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic hydrogenation process for high-purity 2-amino-2-arylethanols using Raney nickel. Offers significant cost reduction and scalability for pharmaceutical intermediates.
Novel solid-phase secondary cyclization method for plecanatide ensures high purity and yield. Offers significant supply chain advantages for pharmaceutical intermediates manufacturing.
Advanced hybrid synthesis patent CN106589069B ensures high purity oxytocin. Reduces costs and improves supply chain reliability for pharmaceutical manufacturers globally.
Advanced patent CN119080860A details a novel refining method for 17α-hydroxyprogesterone ensuring high purity and yield for scalable pharmaceutical intermediates manufacturing supply chains.
Novel solid-phase method using ester-bond transamidation improves purity and yield for GLP-1 analogs. Cost-effective manufacturing solution for pharmaceutical intermediates.
Patent CN111732649B details continuous flow solid-phase synthesis for liraglutide, offering high purity, reduced solvent use, and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN116836046B enables high-purity 4-Biphenylformaldehyde production. Achieve cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Enzymatic synthesis patent CN100396782C offers high purity stable isotope labeled amino acids with streamlined extraction and superior 15N utilization for research.
Patent CN106478805A details a novel fragment condensation method enhancing purity and yield for GLP-1 derivatives, offering significant supply chain and cost advantages for manufacturers.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Patent CN112266364A reveals a metal-free hydrogenation method for tetrahydroquinoxalines using organic catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.
Novel AlCl3 catalyzed route for prucalopride intermediate. High yield, safe scale-up, cost-effective manufacturing for global supply chains.
Advanced solid-phase synthesis of Liraglutide ensuring high purity and yield. Reliable supplier for pharmaceutical intermediates with scalable processes and cost efficiency.
Novel NBS method for 3-bromo-N-aryl propionamide. Green synthesis, cost reduction, reliable supply chain for pharma intermediates.
Patent CN106146648B reveals a novel fragment condensation strategy for Abaloparatide, offering superior purity and yield for reliable peptide API intermediate manufacturing.
Patent CN105272918A reveals a novel ionic liquid synthesis improving yield. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN116478022B reveals a novel ketone synthesis method offering mild conditions and high stereointegrity, ensuring cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106478747B reveals high-yield sulfonated sugar synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel synthetic route for Aztreonam using acetic acid and hydrochloric acid deprotection, offering high purity and scalable production for pharmaceutical intermediates.